Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin.

P E Chabrier1, P Braquet

  • 1Institut Henri-Beaufour, Les Ulis, France.

Hormone Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Endothelin (ET), a peptide from endothelium, causes sustained vasoconstriction and blood pressure changes. Further research into ET receptor antagonists and biosynthesis inhibitors is needed to clarify its biological roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravitreally injected platelet activating factor induces retinitis in experimental animals.

Current eye research·1999
Same author

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies.

European urology·1998
Same author

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils.

Prostaglandins, leukotrienes, and essential fatty acids·1997
Same author

The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis.

Gastroenterology·1996
Same author

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.

Pharmacological research·1996
Same author

A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice.

Nuclear medicine and biology·1996
Same journal

Abstracts of the LWPES/ESPE 8th Joint Meeting Global Care in Paediatric Endocrinology, in collaboration with APEG, APPES, JSPE and SLEP. New York City, New York, USA. September 9-12, 2009.

Hormone research·2011
Same journal

Abstracts of the 47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Istanbul, Turkey. September 20-23, 2008.

Hormone research·2011
Same journal

Abstracts of the 46th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Helsinki, Finland. June 27-30, 2007.

Hormone research·2011
Same journal

Genetic and pathogenetic aspects of Noonan syndrome and related disorders.

Hormone research·2009
Same journal

Response to growth hormone in short children with Noonan syndrome: correlation to genotype.

Hormone research·2009
Same journal

Growth hormone and the heart in Noonan syndrome.

Hormone research·2009
See all related articles

Area of Science:

  • Biochemistry
  • Pharmacology
  • Physiology

Background:

  • Endothelin (ET) is a family of 21 amino acid peptides with at least three human isoforms.
  • Originally identified as an endothelium-derived vasoconstrictive substance, ET is released from a precursor peptide by a specific ET-converting enzyme.
  • ET exerts various pharmacological effects via its specific receptors.

Purpose of the Study:

  • To elucidate the mechanism of action of Endothelin (ET).
  • To understand the biological relevance of Endothelin (ET) as a signaling molecule.
  • To investigate the role of ET in vascular contraction and blood pressure regulation.

Main Methods:

  • Studies on isolated vascular preparations to observe contraction.
  • In vivo studies to assess pressor effects and blood pressure changes.

Related Experiment Videos

  • Investigation of ET's effects on phospholipase C and protein kinase C signaling pathways.

    • Main Results:

    • ET induces sustained and poorly reversible contraction of isolated vascular preparations.
    • In vivo, ET causes a long-lasting pressor effect, preceded by transient hypotension.
    • ET stimulation of phospholipase C and protein kinase C has been observed.

    Conclusions:

    • Endothelin (ET) plays a significant role in vascular contraction and blood pressure regulation.
    • ET likely functions as a paracrine or autocrine signal rather than a circulating hormone.
    • The development of specific ET receptor antagonists and biosynthesis inhibitors is crucial for understanding its biological significance.